Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Accenture
Novartis
Federal Trade Commission
US Army
McKesson
Harvard Business School
Argus Health
Colorcon
Mallinckrodt

Generated: February 19, 2018

DrugPatentWatch Database Preview

Tolazamide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for tolazamide and what is the scope of tolazamide freedom to operate?

Tolazamide
is the generic ingredient in two branded drugs marketed by Barr, Duramed Pharms Barr, G And W Labs Inc, Interpharm, Mylan Pharms Inc, Par Pharm, Sun Pharm Industries, Superpharm, Usl Pharma, Watson Labs, Yaopharma Co Ltd, and Pharmacia And Upjohn, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for tolazamide. Two suppliers are listed for this compound.
Pharmacology for tolazamide
Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea
Medical Subject Heading (MeSH) Categories for tolazamide

US Patents and Regulatory Information for tolazamide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs TOLAZAMIDE tolazamide TABLET;ORAL 070242-001 Aug 1, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
G And W Labs Inc TOLAZAMIDE tolazamide TABLET;ORAL 018894-002 Nov 2, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn TOLINASE tolazamide TABLET;ORAL 015500-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Industries TOLAZAMIDE tolazamide TABLET;ORAL 071359-001 Jul 16, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
G And W Labs Inc TOLAZAMIDE tolazamide TABLET;ORAL 018894-003 Nov 2, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs TOLAZAMIDE tolazamide TABLET;ORAL 070515-001 Jan 9, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Superpharm TOLAZAMIDE tolazamide TABLET;ORAL 070764-001 Jun 16, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc TOLAZAMIDE tolazamide TABLET;ORAL 070259-001 Jan 2, 1986 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Barr TOLAZAMIDE tolazamide TABLET;ORAL 070164-001 Jan 14, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm TOLAZAMIDE tolazamide TABLET;ORAL 070161-001 Jan 6, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Covington
Queensland Health
Farmers Insurance
Accenture
Chinese Patent Office
Cantor Fitzgerald
Chubb
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot